Literature DB >> 22733159

Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations.

C K M Ho1, L Halley, J Wei, F K Habib.   

Abstract

BACKGROUND: Both genetics and the environment are implicated as risk factors for prostate cancer (PCa). This population-based case-control study evaluated four single-nucleotide polymorphisms (SNPs) previously identified by genome-wide association studies to be associated with increased PCa susceptibility. Potential relationships between serum concentrations of phyto-estrogens and SNPs were also investigated.
METHODS: Four SNPs (rs10993994, rs2660753, rs1016343 and rs6983267) were genotyped in 247 PCa patients, 125 BPH patients and 274 control men recruited in Scotland. Serum concentrations of the phyto-estrogens enterolactone, equol, genistein and daidzein were measured by isotope dilution gas chromatography-mass spectrometry.
RESULTS: Increased PCa risk was associated with TT genotype of rs10993994 compared with CC and CT genotypes combined (odds ratio (OR)=1.87; 95% confidence interval (CI), 1.26-2.77). TT homozygotes who had low serum enterolactone concentrations (below median) were more likely to have PCa (OR=2.90; 95% CI, 1.28-6.57) than individuals with CC/CT genotype and high serum enterolactone concentrations (above median). PCa was not associated with the other three SNPs tested.
CONCLUSIONS: PCa susceptibility was associated with TT genotype of SNP rs10993994 in this cohort of Scottish men and the increased risk of PCa was modified by serum enterolactone concentrations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733159     DOI: 10.1038/pcan.2012.24

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  7 in total

Review 1.  Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives.

Authors:  Aniket V Mali; Subhash B Padhye; Shrikant Anant; Mahabaleshwar V Hegde; Shivajirao S Kadam
Journal:  Eur J Pharmacol       Date:  2019-02-14       Impact factor: 4.432

2.  Association of single nucleotide polymorphism rs6983267 with the risk of prostate cancer.

Authors:  Yuan Yang; Wenjing Wang; Liangcai Zhang; Shihua Zhang; Guiyou Liu; Yingcui Yu; Mingzhi Liao
Journal:  Oncotarget       Date:  2016-05-03

3.  Association between 8q24 Gene Polymorphisms and the Risk of Prostate Cancer: A Systematic Review and Meta-Analysis.

Authors:  Ran Li; Zhiqiang Qin; Jingyuan Tang; Peng Han; Qianwei Xing; Feng Wang; Shuhui Si; Xiaolu Wu; Min Tang; Wei Wang; Wei Zhang
Journal:  J Cancer       Date:  2017-09-15       Impact factor: 4.207

4.  Association between 8q24 rs6983267 polymorphism and cancer susceptibility: a meta-analysis involving 170,737 subjects.

Authors:  Man Zhu; Xue Wen; Xuefang Liu; Yingchao Wang; Chunzi Liang; Jiancheng Tu
Journal:  Oncotarget       Date:  2017-07-04

5.  MSMB gene rs10993994 polymorphism increases the risk of prostate cancer.

Authors:  Tao Peng; Lifeng Zhang; Lijie Zhu; Yuan-Yuan Mi
Journal:  Oncotarget       Date:  2017-04-25

6.  The rs10993994 in the proximal MSMB promoter region is a functional polymorphism in Asian Indian subjects.

Authors:  Deepa R Mhatre; Smita D Mahale; Mohammed I Khatkhatay; Swati K Achrekar; Swapna S Desai; Dhanashree D Jagtap; Jayesh V Dhabalia; Hemant B Tongaonkar; Sucheta P Dandekar; Anand M Varadkar
Journal:  Springerplus       Date:  2015-07-28

7.  Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men.

Authors:  Peter Wallström; Isabel Drake; Emily Sonestedt; Bo Gullberg; Anders Bjartell; Håkan Olsson; Herman Adlercreutz; Matti J Tikkanen; Elisabet Wirfält
Journal:  Eur J Nutr       Date:  2017-09-07       Impact factor: 5.614

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.